References
  1. Limaiem F, Rehman A, Mazzoni T Papillary Thyroid Carcinoma 2022
  2. Kant R, Davis A, Verma V Thyroid Nodules: Advances in Evaluation and Management. Am Fam Physician 2020;102 (5):298-304
  3. NIH Surveillance, Epidemiology, and End Results Program: Cancer Statistics Explorer (Accessed 12/2021).
  4. Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. J Natl Compr Canc Netw 2018;16 (12):1429-1440